MCCQE Part 1 Pass Rate, Format and Difficulty (2026)
Current MCCQE Part 1 format, scoring and pass rates for 2026 — the move to a fully MCQ exam, the new 300-to-600 scale and 439 pass score, and CMG vs IMG pass rates.
Read Insight
blog
insights on clinical AI, guideline access, and the future of medicine
Making a Decision?
See objective, head-to-head comparisons of iatroX against other clinical tools.
USMLE Step 1 and Step 2 CK Pass Rates and Difficulty (2026)
Current USMLE Step 1 and Step 2 CK pass rates, passing standards, and difficulty for 2026 — the pass/fail change, the 196 and 218 standards, and what the numbers mean for your prep...
Read InsightUWorld Alternatives for the USMLE (2026)
The best UWorld alternatives for the USMLE in 2026 — AMBOSS, Kaplan, Lecturio, Sketchy, Anki and iatroX — for a cheaper option, a second bank, or a different study style.
Read InsightBest USMLE Step 2 CK Question Banks (2026): An Honest Comparison
An honest 2026 comparison of the best USMLE Step 2 CK question banks — UWorld, AMBOSS, Kaplan, TrueLearn, Lecturio and iatroX — now that Step 2 CK is the score residencies weigh mo...
Read InsightBest USMLE Step 1 Question Banks (2026): An Honest Comparison
An honest 2026 comparison of the best USMLE Step 1 question banks — UWorld, AMBOSS, Kaplan, Lecturio, free tools and iatroX — with the right pick for your budget and learning style...
Read InsightCommunity-Acquired Pneumonia (CAP): High-Yield Review for USMLE Step 1 and Step 2 CK (2026)
High-yield CAP review for USMLE Step 1 and Step 2 CK — the 2019 IDSA/ATS guideline, PSI vs CURB-65, empiric antibiotics by setting, the retired HCAP category, and the board traps.
Read InsightSepsis and Septic Shock: High-Yield Review for USMLE Step 1 and Step 2 CK (2026)
High-yield sepsis and septic shock review for USMLE Step 1 and Step 2 CK — Sepsis-3 definitions, the Hour-1 bundle, norepinephrine, and the board traps.
Read InsightAcute Coronary Syndrome (ACS): High-Yield Review for USMLE Step 1 and Step 2 CK (2026)
High-yield ACS review for USMLE Step 1 and Step 2 CK — ECG and troponin, the 2025 ACC/AHA reperfusion and antiplatelet strategy, secondary prevention, and the board traps.
Read InsightDiabetic Ketoacidosis (DKA): High-Yield Review for USMLE Step 1 and Step 2 CK (2026)
High-yield DKA review for USMLE Step 1 and Step 2 CK — the 2024 ADA criteria, the fluids/insulin/potassium protocol, resolution, and the board traps, in US units.
Read InsightChronic Asthma Management: High-Yield Revision for MRCP, UKMLA and MSRA (2026)
High-yield chronic asthma management revision for MRCP, UKMLA and MSRA — the 2024 shift away from SABA, the AIR and MART pathway, FeNO and eosinophil-guided escalation, and the exa...
Read InsightChronic Kidney Disease (CKD): High-Yield Revision for MRCP, UKMLA and MSRA (2026)
High-yield chronic kidney disease revision for MRCP, UKMLA and MSRA — the GFR/ACR classification, ACEi/ARB and SGLT2 inhibitor therapy, referral thresholds, and the exam traps.
Read InsightHypertension: High-Yield Revision for MRCP, UKMLA and MSRA (2026)
High-yield hypertension revision for MRCP, UKMLA and MSRA — ABPM-confirmed staging, the A/C/D treatment algorithm, blood pressure targets, resistant hypertension, and the exam trap...
Read Insight